Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia

Online veröffentlicht: 29. Dez. 2017

Seitenbereich: 343 - 347

Eingereicht: 05. Juli 2016

Akzeptiert: 28. Juli 2016

DOI: https://doi.org/10.1515/sjecr-2016-0070

Schlüsselwörter

rheumatoid arthritis, biological therapy, etanercept, cost-effectiveness analysis

© 2017 Marina Kostic, published by De Gruyter Open

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.